EDGAR Filing Documents for 0001607062-15-000129

Form 8-K - Current report:

SEC Accession No. 0001607062-15-000129

Filing Date

2015-03-25

Accepted

2015-03-24 19:00:44

Documents

Period of Report

2015-03-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	rgbp20150324form8k.htm	8-K	51200
2	CONVERTIBLE PROMISSORY NOTE	rgbp20150324form8kex10_1.htm	EX-10.1	23511
3	CONVERTIBLE PROMISSORY NOTE	rgbp20150324form8kex10_2.htm	EX-10.2	23536
4	SUBLEASE AGREEMENT	rgbp20150324form8kex10_3.htm	EX-10.3	42899
5	RESEARCH AGREEMENT	rgbp20150324form8kex10_4.htm	EX-10.4	31378
	Complete submission text file	0001607062-15-000129.txt		173664

Mailing Address 4700 SPRING ST #304 LA MESA CA 91942

Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404

Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)